Fusion Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three
Fusion Pharmaceuticals Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Three of $1.32 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree · last filed 2024-05-07
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $1.32M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.41M.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.40M.
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.36M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Three |
|---|---|
| 2024-03-31 | $1.32M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $2.41M 10-K · filed 2024-03-20 |
| 2023-09-30 | $2.40M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.36M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.34M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.57M 10-K · filed 2023-03-16 |
| 2022-09-30 | $1.57M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.59M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.60M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.50M 10-K · filed 2022-03-17 |
| 2021-09-30 | $1.50M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.51M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.50M 10-Q · filed 2021-05-11 |